Lamotrigine - generic product ( DrugBank: Lamotrigine )

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
38スティーヴンス・ジョンソン症候群1

38. スティーヴンス・ジョンソン症候群

臨床試験数 : 17 /  薬物数 : 29 - (DrugBank : 9) / 標的遺伝子数 : 15 - 標的パスウェイ数 : 101
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2012-003136-23-GB
(EUCTR)		27/11/201216/11/2012Lamotrigine And Borderline Personality Disorder: Investigating Long-Term EffectivenessLamotrigine And Borderline Personality Disorder: Investigating Long-Term Effectiveness - LABILE Borderline Personality Disorder
MedDRA version: 14.1;Level: PT;Classification code 10042033;Term: Stevens-Johnson syndrome;System Organ Class: 10040785 - Skin and subcutaneous tissue disorders
MedDRA version: 14.1;Classification code 10019211;Term: Headache;System Organ Class: 10029205 - Nervous system disorders
MedDRA version: 15.0;Level: LLT;Classification code 10028821;Term: Nausea with vomiting;System Organ Class: 100000004856
MedDRA version: 14.1;Classification code 10040913;Term: Skin rash;Classification code 10024264;Term: Lethargy;System Organ Class: 10029205 - Nervous system disorders
MedDRA version: 14.1;Classification code 10013649;Term: Drowsiness;System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]		Trade Name: Lamotrigine - generic product
Product Name: Lamotrigine
Product Code: n/a
INN or Proposed INN: Lamotrigine
Other descriptive name: 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine		Imperial College LondonNULLNot Recruiting Female: yes
Male: yes		252 Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): yesUnited Kingdom